BNTX
BioNTech (BNTX)
$81
About BioNTech (BNTX)
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
Details
Daily high
$94.75
Daily low
$93.63
Price at open
$94.52
52 Week High
$129.27
52 Week Low
$81.20
Market cap
22.8B
Dividend yield
0.00%
Volume
974,161
Avg. volume
1.4M
P/E ratio
-36.04
BioNTech News
Details
Daily high
$94.75
Daily low
$93.63
Price at open
$94.52
52 Week High
$129.27
52 Week Low
$81.20
Market cap
22.8B
Dividend yield
0.00%
Volume
974,161
Avg. volume
1.4M
P/E ratio
-36.04